|
|
|
| |
|
Roche revamps research ops, cuts 1,000 U.S. jobs
|
Jun 26, 2012
|
| |
|
<p><a href="http://news.yahoo.com/roche-cuts-1-000-u-jobs-closing-nj-163936724--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/czL44FKbrpE2239tWHczOA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-06-26T193725Z_1_CBRE85P1AA300_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" align="left" title="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" border="0" /></a>ZURICH/NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG said on Tuesday it was overhauling its research operations by closing the 80-year-old New Jersey facility where Valium was discovered, cutting 1,000 jobs and replacing its drug research chief. Jean-Jacques Garaud, head of pharmaceutical research, will leave the company at the end of this week, Roche said. He will be replaced by Mike Burgess, head of cancer drugs. Roche will also shutter its 127-acre Nutley, N.J.-based campus and move those activities to Germany and Switzerland, a consolidation aimed at curbing drug development costs. ...</p><br clear="all"/>
|
| |
|
|
|
|
 |
|
 |
|
|
|
